12/20
09:56 am
qnrx
Quoin Pharmaceuticals announces pricing of $6.8 million public offering [Seeking Alpha]
Medium
Report
Quoin Pharmaceuticals announces pricing of $6.8 million public offering [Seeking Alpha]
12/20
09:20 am
qnrx
Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering
Low
Report
Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering
12/19
08:07 am
qnrx
Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study [Yahoo! Finance]
High
Report
Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study [Yahoo! Finance]
12/19
08:00 am
qnrx
Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study
High
Report
Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study
12/18
08:20 am
qnrx
Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies [Yahoo! Finance]
High
Report
Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies [Yahoo! Finance]
12/18
08:18 am
qnrx
Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies
Medium
Report
Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies
11/7
08:00 am
qnrx
Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2024 Financial Results
Medium
Report
Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2024 Financial Results
11/5
08:00 am
qnrx
Quoin Pharmaceuticals Initiates Clinical Testing of Lead Product in Pediatric Netherton Syndrome Patient
Neutral
Report
Quoin Pharmaceuticals Initiates Clinical Testing of Lead Product in Pediatric Netherton Syndrome Patient
10/31
04:05 pm
qnrx
Quoin Pharmaceuticals to Announce Third Quarter 2024 Financial Results on Thursday, November 7, 2024
Low
Report
Quoin Pharmaceuticals to Announce Third Quarter 2024 Financial Results on Thursday, November 7, 2024
10/22
08:00 am
qnrx
Quoin Pharmaceuticals Announces Further International Expansion of Ongoing Clinical Trials for Netherton Syndrome
High
Report
Quoin Pharmaceuticals Announces Further International Expansion of Ongoing Clinical Trials for Netherton Syndrome